Research Article
Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport
Table 1
The demographics, underlying conditions, admission diagnoses, laboratory data, and therapeutic management during the ICU stay.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Group 1: critically ill patients who were not transported outside of the ICU during their hospitalization period. Group 2: critically ill patients who were transported outside of the ICU during iNO treatment during their hospitalization period. Data are considered statistically significant if . Other diagnoses include intracerebral hemorrhage, cardiogenic shock, eclampsia, SAH, NSTEMI, and pulmonary edema. Vasopressor support: norepinephrine continuous infusion; steroid treatment: concomitant hydrocortisone administration. aICU: intensive care unit. bSD: standard deviation. cAPACHE: Acute Physiology and Chronic Health Evaluation on admission to ICU.. dTISS: Therapeutic Intervention Scoring System on admission to ICU. eWBC: white blood cells. fCIHD: chronic ischemic heart disease. gCOPD: chronic obstructive pulmonary disease. hHTN: chronic hypertension. IOther: diabetes mellitus II, dyslipidemia, alcohol abuse, fat embolism, and pulmonary embolism. |